000 02238nam a22003735i 4500
988 _aSpringer_Medicine_2015
999 _c82004
_d82004
_x1
001 82004
003 ES-MaUEC
005 20230207040350.0
007 cr nn 008mamaa
008 141127s2015 xxu| s |||| 0|eng d
020 _a9781493916221
024 7 _a10.1007/978-1-4939-1622-1
_2doi
040 _cES-MaUEC
050 4 _aRC280.K5
_b2015 EB
245 1 0 _aRenal Cell Carcinoma :
_bMolecular Targets and Clinical Applications
_cedited by Ronald M. Bukowski, Robert A. Figlin, Robert J. Motzer.
250 _a3rd ed. 2015.
260 _aNew York
_bSpringer
_c2015
300 _a1 recurso en línea (XVIII, 613 páginas)
_b50 ilustraciones, 41 ilustraciones en color
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
520 3 _aThe third edition of this critically acclaimed book has updated and expanded the survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. Internationally renowned editors and contributors explore the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors. Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Third Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by leaders of the field.
650 7 _aMedicina nuclear
_2embne
_9138396
700 1 _aBukowski, Ronald M
_eeditor literario
_944355
700 1 _aFiglin, Robert A.
_eeditor literario
_0Local
_994630
700 1 _aMotzer, Robert J
_eeditor literario
_990548
_0Local
710 2 _aSpringerLink (Online service)
_0Local
_9106996
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-4939-1622-1
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907 _a.b12906438
_b10-10-17
_c10-02-16
942 _2lcc
_cLE
945 _aRC280.K5 R463 2015 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11574124
_z06-04-17
998 _am
_a_alco
_a_vill
_b - -
_cm
_dz
_e-
_feng
_gxxu
_h0